A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors
摘要:
By inserting an oxygen link between the 3-fluorophenyl and the lactone ring of 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methanesulfonylphenyl)-2(5H)-furanone 1 (DFU), analogs with enhanced in vitro COX-2 inhibitory potency as well as in vivo potency in models of inflammation were obtained, (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors
摘要:
By inserting an oxygen link between the 3-fluorophenyl and the lactone ring of 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methanesulfonylphenyl)-2(5H)-furanone 1 (DFU), analogs with enhanced in vitro COX-2 inhibitory potency as well as in vivo potency in models of inflammation were obtained, (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitors
申请人:Merck Frosst Canada, Inc.
公开号:US05698584A1
公开(公告)日:1997-12-16
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
申请人:Merck Frosst Canada, Inc.
公开号:US06020343A1
公开(公告)日:2000-02-01
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
Alkylated styrenes as prodrugs to COX-2 inhibitors
申请人:Merck Frosst Canada, Inc.
公开号:US05789413A1
公开(公告)日:1998-08-04
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
[EN] (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES AS COX-2 INHIBITORS<br/>[FR] (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES EN TANT QU'INHIBITEURS DU COX-2
申请人:MERCK FROSST CANADA INC.
公开号:WO1997014691A1
公开(公告)日:1997-04-24
(EN) The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).(FR) Cette invention, qui porte sur le nouveau composé répondant à la formule (I), composé s'avérant efficace dans le traitement de maladies liées à la cyclo-oxygénase-2, a également trait à certaines compositions pharmaceutiques qui, contenant des composés de ladite formule (I), servent à traiter lesdites maladies.